| |
Tuesday, October 11, 2022 | 2pm ET / 11am PT Drug rebates are complex and the subject of legislative influence, creating a uniquely challenging ecosystem where gaps in knowledge, data and technology can create challenges. Register now to learn how manufacturers can respond quickly to changes in policies. 
|
|
| By Nick Paul Taylor Merck KGaA has extended its collaboration with Biocorp. The German drugmaker has signed up to work with Biocorp to develop a version of a Bluetooth enabled clip-on device that is specific to one of its drug delivery devices. |
|
|
|
By Nick Paul Taylor Eisai’s ¥10 billion ($69 million) bet on injectable drug delivery is complete. The Japanese drug developer plowed the money into the construction of an injectable formulation research building, positioning it to continue its expansion beyond oral drug delivery. |
By Nick Paul Taylor Questions about an infusion device have scuttled Supernus Pharmaceuticals’ attempt to win approval of a Parkinson’s disease therapy. The complete response letter marks the second time in two years that the FDA has knocked back a filing for approval of the continuous treatment of motor fluctuations. |
By Nick Paul Taylor The NIH has agreed to fund development of a nasally administered gonorrhea vaccine. Intravacc secured the financial support, landing a $14.6 million contract as it works to move its NGoXIM candidate into a phase 1 trial. |
|
Wednesday, October 19th 2022 | 2:00 PM ET / 11:00 AM PT Products are being studied for multiple indications while also being developed in multiple presentations. Planning for success has now become multi-dimensional, and organizations must continue to stay launch ready. Register now. 
|
|
By Kevin Dunleavy After five years and two unsuccessful attempts, scPharmaceuticals has finally pushed its on-body infusor for the treatment of congestive heart failure across the FDA finish line. Furoscix becomes the first self-administered, subcutaneous loop diuretic for those with worsening HF. |
Fierce podcasts Don't miss an episode |
| This week on "The Top Line," we talk about trial results for Eisai and Biogen's Alzheimer’s drug, which were surprisingly good, and we dig into what comes next. We also discuss how Pfizer is ramping up its DTC ad campaign for its COVID shots, most recently spending big on a booster ad for the NFL season. |
|
|---|
|
|
|
Now Available On Demand This panel will discuss leveraging technology and home health solutions to augment existing points of care between patients and their clinical care team to improve the patient experience, drive more scientific rigor to data generation and achieve timely endpoint capture. Watch now. 
|
|
eBook Looking to implement a remote patient monitoring (RPM) program at your organization? Download the eBook from Health Catalyst to learn the essential components of successful RPM programs. Sponsored by: Health Catalyst |
eBook In this free guide, explore how Cloud Computing is enabling emerging biopharma organizations to decrease time-to-discovery in pursuit of breakthrough treatment modalities. Sponsored by: RCH Solutions |
Whitepaper Learn the benefits of unlocking data insights across the healthcare and life sciences ecosystem. Sponsored by: NTT Data |
eBook With real-world data playing a significant role in health care decisions, life sciences leaders need to maximize their data investments. The best place to start is right here, with our e-book on the four steps to a more coordinated, connected real-world data strategy. Sponsored by: Optum |
Whitepaper This paper is the first in a 4-part series focused on developing commercial models for gene therapies Sponsored by: Blue Matter, strategic consultants in the life sciences |
Whitepaper SaaS LIMS from LabVantage Solutions Is Pre-Validated for Regulated Industries, Delivering Maximum Flexibility, Uptime, and Security. Sponsored by: LabVantage Solutions Inc. |
Whitepaper Supporting your product development programme through experience, expertise, and efficiency. Sponsored by: Almac Pharma Services |
Video Can an optimized research process--including AI-powered workflow and process automation tools--help get breakthrough drugs to market faster? Sponsored by: Proscia |
Video Learn how a centralized platform for pathology images, metadata, and analysis results can connect previously siloed research initiatives and advance our collective understanding of tissue. Sponsored by: Proscia |
Whitepaper What is the most suitable dosage form technology for the Oral Delivery of Lipid-Based Formulations? Sponsored by: Catalent |
Research Learn more about how the versatility of Softgel Technology helped a customer with a volatile compound. Sponsored by: Catalent |
Whitepaper How can Lipid-Based Drug Delivery System help bring poorly soluble drugs to market? Sponsored by: Catalent |
Webinar Ypsomed and Catalent Biologics experts discuss strategies for integrated PFS manufacturing and auto-injector assembly to accelerate timelines and more in this webinar. Sponsored by: Catalent Biologics |
Whitepaper Learn how formulation development for a PFS affects manufacturing to drive the industry toward optimizing delivery of injectable products and, ultimately, improving patient care. Sponsored by: Catalent Biologics |
Custom Resource Center Read through this library of resources to find out how you can strengthen innovation and efficiency, improve safety and quality, and prioritize resources to support your long-term goals. Sponsored by: JLL |
Whitepaper Clarus Therapeutics (Clarus) is a men’s specialty pharmaceutical company that partnered with Catalent to develop a unique and convenient drug delivery form for their hormone replacement therapy. Sponsored by: Catalent |
Whitepaper Learn more about how the transition from early to late phase of a small molecule program plays a pivotal role in a program’s ultimate success. Sponsored by: Catalent |
Whitepaper Explore how Thermo Scientific’s Process Liquid Preparation Services can help you plan for scalable buffer preparation. Sponsored by: Thermo Fisher Scientific |
| |
|
